Scientific Breakthrough in Alopecia Treatment?
There’s some potentially good news awaiting hair loss sufferers as Danish pharmaceutical firm LEO Pharma announces major investment into biotech company Novopyxis.
Why? To support USA-based Novopyxis and their pioneering development of a sophisticated drug delivery device. The device is designed to increase the penetration of topical treatments.
The first people to be clinically tested will be alopecia sufferers. The aim is to find an alternative alopecia treatment to replace painful steroid injections with limited impact.
LEO Pharma’s investment enables validation of the tech in a clinical study of alopecia patients. The results remain to be seen but the future certainly looks promising.
The Rejuvenate Hair Clinic is an esteemed hair loss treatment centre with a prime location on London’s Harley Street. If you wish to talk through any queries regarding alopecia treatment with our experienced surgeons, book an appointment using our Instant Online Booking System. You can also give us a call on 0845 222 12 02, email email@example.com or use our Online Diagnostics Tool for an expert consultation.